Pomalidomide

Another Name
Pomalyst,泊马度胺
Indications
Multiple Myeloma
Reg No
12L1281/24 12L1283/24
Inspection No
3151-24 3150-24
dosage form:Capsules
Specs:2mg/ 4mg * 21 Capsules
Indate:2 Years
Date:2025-3-5 Views:954

Each capsule contains Pomalidomide……………………………..2mg.

Each capsule contains Pomalidomide……………………………..4mg.

INDICATIONS:

LuciPoma is a thalidomide analogue indicated, for the treatment of adult patients:

  • In combination with dexamethasone, for patients with within 60 days of completion of the last therapy.
  • With AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART) or in patients with KS who are HIV-negative.

DOSAGE AND USE:

  • MM: 4 mg per day taken orally on Days 1 through 21 of repeated 28-day cycles until disease progression.
  • KS: 5 mg per day taken orally on Days 1 through 21 of repeated 28-day cycles until disease progression or unacceptable toxicity.

If you miss a dose of LuciPoma and it has been less than 12 hours since your regular time, take it as soon as you remember. If it has been more than 12 hours, just skip your missed dose. Do not take 2 doses at the same time.

STORAGE:

In a dry place and store at 20°C to 25°C.

WARNING:

Keep medicine out of reach of Children. Do not administer LuciPoma during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/pomalidomide/

Related News